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PreviewsEXtENDINg b cell survival
by UPRegulating ATF4 translation
In this issue ofCellMetabolism, Daniel Drucker and colleagues (Yusta et al., 2006) explore how the incretinmimetic exendin-4
improvesb cell function and survival duringERstress. Their findings suggest that protein kinaseAsignaling elicited byGLP-1
receptor activation differentially modulates one arm of the unfolded protein response (UPR). Regulation of this UPR pathway
leads to enhanced translational expression of ATF4, a transcription factor central for stress remedy and cell survival.A central question in the study of Type II
diabetes is why sustained insulin resis-
tance in the periphery results in the pro-
gressive loss of b cells in pancreatic islets.
Recent advances in our understanding
of the unfolded protein response (UPR)
in the development of insulin resistance,
as well as the control of pancreatic islet
health, increasingly point to the impor-
tance of maintaining homeostasis in the
endoplasmic reticulum (ER) to achieve
successful glucose control. This unifying
concept now extends to the mechanism
of current treatment modalities. In this is-
sue of Cell Metabolism, Daniel Drucker
and colleagues (Yusta et al., 2006) ad-
dress how the incretin mimetic exendin-4
influences the cellular decision-making
process for whether b cells undergoing
ER stress live or die.
Exendin-4 is a glucagon-like peptide-1
(GLP-1) receptor agonist and the first
incretin mimetic to be approved by the
FDA (in 2005). The incretins are a family
of peptide hormones that are secreted
into the bloodstream by intestinal cells
in response to nutrient entry into the gut
(Drucker, 2003, 2006). GLP-1 and its
analog stimulate production of cAMP by
binding to specific receptors on the
surface of the cell. The biological actions
of exendin-4 in models of type II diabetes
include enhancing insulin sensitivity pe-
ripherally while increasing insulin pro-
duction in the pancreatic islets. This last
finding is of central importance in the
study by Yusta et al. (2006), which ex-
plores how raising intracellular cAMP
improves b cell function and survival
during ER stress. Their findings suggest
that protein kinase A signaling elicited
by the GLP-1 receptor (GLP-1R) differen-
tially modulates one arm of the UPR,
specifically PERK (also known as PEK/
EIF2AK3) phosphorylation of eIF2, which
controls global protein synthesis and
regulates translational expression of the
basic zipper transcription factor ATF4
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Secretory proteins such as insulin are
transferred into the ER, where they are
folded, modified, and assembled into
mature proteins.When themanufactured
cargo on this cellular assembly line is un-
able to be shipped out in balance with its
production, activation of the UPR allevi-
ates the client load by coordinating trans-
lational and transcriptional regulatory
mechanisms to cope with the increased
ER demands (Marciniak and Ron, 2006;
Schroder and Kaufman, 2005). Failure
of the UPR to appropriately address the
imbalance in protein production versus
secretion causes cellular dysfunction
and disease.
A triad of stress sensors monitor envi-
ronmental perturbations in the ER and
elicit a temporal pattern of gene expres-
sion that collectively enhances process-
ing, assembly, and transport of secretory
proteins while downregulating nascent
protein synthesis (Marciniak and Ron,
2006; Schroder and Kaufman, 2005).
One stress sensor, ATF6, is a Golgi mem-
brane-associated protein that, upon pro-
teolytic cleavage, traffics into the nucleus
to direct the transcription of genes sub-
ject to the UPR. The second sensor is
IRE1, a transmembrane ER protein ki-
nase, whose associated RNase activity
is important for splicing XBP-1 mRNA
into a potent transcription factor that
also serves to direct the transcription of
UPR target genes. IRE1 is linked to obe-
sity and peripheral insulin resistance by
recruiting the scaffolding protein TRAF2
to the ER membrane, resulting in MAPK
activation and JNK-dependent serine
phosphorylation of IRS-1 (Marciniak and
Ron, 2006). The third UPR sensor is
PERK, another ER transmembrane pro-
tein kinase that is activated upon dimer-
ization. During ER stress, PERK re-
presses general protein synthesis via
phosphorylation of eIF2, which reduces
the levels of eIF2-GTP required for asso-
ciation of initiator tRNA to the translation2006 ª2006 ELSEVIER INC.apparatus. The resulting lowered protein
synthesis would prevent further overload
of the ER and provide the cell sufficient
time to reconfigure gene expression.
ATF4 translation and b cell survival
Concomitant with reduced general trans-
lation, eIF2 phosphorylation leads to
preferential translation of ATF4. ATF4
has two upstream open reading frames
(uORFs) that are inhibitory and normally
block downstream ATF4 expression (Lu
et al., 2004; Vattem and Wek, 2004).
During enhanced eIF2 phosphorylation,
the inhibitory function of the uORFs is
bypassed, and instead there is elevated
ATF4 translation. ATF4 functions in con-
junction with the other basic zipper
transcription factors, ATF6 and XBP-1,
to direct transcription in the UPR. Im-
portant targets for ATF4-directed gene
expression are CHOP, which regulates
apoptosis, and GADD34, which serves
in a feedback mechanism to direct type
1 protein phosphatase to dephosphory-
late eIF2 (Figure 1) (Marciniak and Ron,
2006; Schroder and Kaufman, 2005).
Activation of each UPR sensor was
originally thought to occur in a temporally
coordinated fashion. This idea is exem-
plified by the observation that PERK
and IRE1 share related luminal domains
that are proposed to monitor ER stress
via common regulatory mechanisms.
However, recent studies suggest that
there can also be biologically important
differences in the extent of activation of
each UPR sensor (DuRose et al., 2006).
The study by Yusta et al. (2006) paints
a picture in which cAMP activation of
protein kinase A in ER-stressed cells
leads to overinduction of ATF4 transla-
tion downstream of PERK activation.
Importantly, ATF4 enhances GADD34
expression without altering PERK activ-
ity, which would lead to eIF2 dephos-
phorylation and a more rapid recovery
of global protein synthesis. A sustained
increase in ATF4, accompanied by a333
P R E V I E W SFigure 1. Activation of the GLP-1 receptor enhances ATF4 translation and improves b cell survival during ER
stress
The UPR consists of a triad of transmembrane stress sensors, PERK, ATF6, and IRE1, that collectively serve to
control protein synthesis and transcription. GLP-1R agonists such as exendin-4 signal PKA overinduction of
ATF4 translation, potentiating expression of gene products subject to the UPR in response to ER stress. In
addition, ATF4-directed expression of GADD34 targets type 1 protein phosphatase (PP1) to dephosphorylate
eIF2, facilitating a rapid restoration of translation. Together, these responses enhance b cell function and
survival during continued ER stress.more rapid restoration of protein syn-
thesis due to GADD34-mediated de-
phosphorylation of eIF2, may be a key
contributor to enhancement of b cell
adaptation and survival in response to
ER stress.
GLP-1R is widely expressed in the
central nervous system, and the prosur-
vival actions of GLP-1R signaling are
suggested to be important for resistance
to certain neural injuries and for learning.334Therefore, the role of GLP-1R and protein
kinase A signaling in ATF4 translation
regulation may extend beyond b cell
survival. Finally, eIF2 phosphorylation is
mediated by a family of protein kinases
that each respond to different cellular
stress arrangements. For example,
phosphorylation of eIF2 by the GCN2
protein kinase (EIF2AK4) is thought to
be important for remedying metabolic
stress, feeding behaviors, and memoryand learning (Costa-Mattioli et al., 2005;
Wek et al., 2006). It is inviting to speculate
that GLP-1R regulation of ATF4 transla-
tional expression will have broader
applications to diseases involving cyto-
plasmic stress responses regulated by
other eIF2 kinase family members.
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